default author photo

Jong Seok Lee

Seoul National University - Department of Internal Medicine

Seoul

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

3

DOWNLOADS

239

TOTAL CITATIONS

2

Scholarly Papers (3)

1.

A Phase 1b Study of Osimertinib Plus Savolitinib in Patients with EGFR Mutation-Positive, MET-Amplified, Non-Small Cell Lung Cancer after Progression on EGFR-Tyrosine Kinase Inhibitors

Number of pages: 222 Posted: 03 Oct 2019
Harvard University - Department of Medicine, National Cancer Center, Korea, Sungkyunkwan University - Division of Hematology-Oncology, Yonsei University - Yonsei Cancer Center, Memorial Sloan Kettering Cancer Center, University of Ulsan - Department of Oncology, National Taiwan University - Department of Oncology, Seoul National University - Department of Internal Medicine, National Cheng Kung University - Department of Internal Medicine, Maria Skłodowska-Curie Institute of Oncology, BioEq, LLC, AstraZeneca Pharmaceuticals - United Kingdom, AstraZeneca Pharmaceuticals - United Kingdom, AstraZeneca Pharmaceuticals - United Kingdom, AstraZeneca Pharmaceuticals - United Kingdom, AstraZeneca Pharmaceuticals - United Kingdom and Harvard University - Department of Thoracic Oncology
Downloads 131 (561,789)
Citation 1

Abstract:

Loading...

2.

Immunogenicity and Safety of Influenza Vaccination in Cancer Patients Receiving Immune Checkpoint Inhibitor

Number of pages: 34 Posted: 10 May 2019
Seoul National University - Department of Internal Medicine, Seoul National University - Seoul National University Boramae Hospital, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Bundang Hospital, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University Hospital and Seoul National University - Bundang Hospital
Downloads 60 (961,006)
Citation 1

Abstract:

Loading...

Influenza, vaccination, immune checkpoint inhibitor, immunogenicity, immune-related adverse event

3.

A Phase II Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive- and CD30-Positive Lymphomas

Number of pages: 30 Posted: 02 Dec 2020
Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Pathology, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Cancer Research Institute, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine, Seoul National University - Department of Internal Medicine and Seoul National University - Department of Internal Medicine
Downloads 48 (1,097,529)

Abstract:

Loading...